Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima Indians

Lead Sponsor:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Weight Gain

Overweight

Eligibility:

All Genders

18-55 years

Brief Summary

Insulin resistance and a defect in early insulin secretion are risk factors for the development of type 2 diabetes mellitus. A recent longitudinal analysis which tracked the development of diabetes de...

Detailed Description

Insulin resistance and a defect in early insulin secretion are risk factors for the development of type 2 diabetes mellitus. A recent longitudinal analysis which tracked the development of diabetes de...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Subjects from all racial and ethnic backgrounds will be invited to participate if they are:
  • Ages: 18-55 years old (up to 2200 participants)
  • Gender: male or female
  • EXCLUSION CRITERIA:
  • Subjects will be excluded who are:
  • Taking medication for a chronic illness.
  • Have any acute or chronic diseases or conditions not specifically mentioned that in the opinion of the provider may interfere with the study or decrease safety for participation will be considered exclusionary.
  • Women who currently pregnant or breastfeeding.
  • Positive for drug and/or nicotine use.
  • All medications and alcohol consumption are to be stopped for two weeks prior to admission. A urine drug-screening test for drugs such as narcotics, marijuana, and barbiturates will be performed on everyone to exclude from the study people whose urine show active or recent drug use. A positive drug test could confound the results of the study in an unpredictable manner. The results of this test will become a part of the patient s medical records and may be released if requested (please see page 6 of the consent for details regarding medical records release).

Exclusion

    Key Trial Info

    Start Date :

    January 1 1983

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    Estimated Enrollment :

    1759 Patients enrolled

    Trial Details

    Trial ID

    NCT00340132

    Start Date

    January 1 1983

    Last Update

    January 8 2026

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    NIDDK, Phoenix

    Phoenix, Arizona, United States, 85014